These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28930565)

  • 1. Role of fibroblast growth factor receptor-2 splicing in normal and cancer cells.
    Ishiwata T
    Front Biosci (Landmark Ed); 2018 Jan; 23(4):626-639. PubMed ID: 28930565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splicing of fibroblast growth factor receptors in human prostate cancer.
    Kwabi-Addo B; Ropiquet F; Giri D; Ittmann M
    Prostate; 2001 Feb; 46(2):163-72. PubMed ID: 11170144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases.
    Ueda J; Matsuda Y; Yamahatsu K; Uchida E; Naito Z; Korc M; Ishiwata T
    Oncogene; 2014 Sep; 33(36):4485-95. PubMed ID: 24077287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addiction of mesenchymal phenotypes on the FGF/FGFR axis in oral squamous cell carcinoma cells.
    Osada AH; Endo K; Kimura Y; Sakamoto K; Nakamura R; Sakamoto K; Ueki K; Yoshizawa K; Miyazawa K; Saitoh M
    PLoS One; 2019; 14(11):e0217451. PubMed ID: 31682640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of fibroblast growth factor receptorĀ 2 and its isoforms correlates with a high proliferation rate and poor prognosis in high-grade glioma.
    Ohashi R; Matsuda Y; Ishiwata T; Naito Z
    Oncol Rep; 2014 Sep; 32(3):1163-9. PubMed ID: 24968791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition.
    Ranieri D; Rosato B; Nanni M; Magenta A; Belleudi F; Torrisi MR
    Oncotarget; 2016 Feb; 7(5):5440-60. PubMed ID: 26713601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells.
    Grygielewicz P; Dymek B; Bujak A; Gunerka P; Stanczak A; Lamparska-Przybysz M; Wieczorek M; Dzwonek K; Zdzalik D
    Gastric Cancer; 2016 Jan; 19(1):53-62. PubMed ID: 25407459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation.
    Ishiwata T; Matsuda Y; Yamamoto T; Uchida E; Korc M; Naito Z
    Am J Pathol; 2012 May; 180(5):1928-41. PubMed ID: 22440254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancer.
    Matsuda Y; Yoshimura H; Suzuki T; Uchida E; Naito Z; Ishiwata T
    Cancer Sci; 2014 Sep; 105(9):1212-9. PubMed ID: 24975163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGFR2 isoforms support epithelial-stromal interactions in thyroid cancer progression.
    Guo M; Liu W; Serra S; Asa SL; Ezzat S
    Cancer Res; 2012 Apr; 72(8):2017-27. PubMed ID: 22345151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor receptor expression reflects cellular differentiation in human oral squamous carcinoma cell lines.
    Drugan CS; Paterson IC; Prime SS
    Carcinogenesis; 1998 Jun; 19(6):1153-6. PubMed ID: 9667757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice.
    Baraniak AP; Chen JR; Garcia-Blanco MA
    Mol Cell Biol; 2006 Feb; 26(4):1209-22. PubMed ID: 16449636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor Ī²1 signaling in metastatic breast cancers.
    Wendt MK; Taylor MA; Schiemann BJ; Sossey-Alaoui K; Schiemann WP
    Breast Cancer Res; 2014 Mar; 16(2):R24. PubMed ID: 24618085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
    Roy Burman D; Das S; Das C; Bhattacharya R
    Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The choice between alternative IIIb and IIIc exons of the FGFR-3 gene is not strictly tissue-specific.
    Scotet E; Houssaint E
    Biochim Biophys Acta; 1995 Nov; 1264(2):238-42. PubMed ID: 7495869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.
    Warzecha CC; Sato TK; Nabet B; Hogenesch JB; Carstens RP
    Mol Cell; 2009 Mar; 33(5):591-601. PubMed ID: 19285943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
    Zhao Q; Caballero OL; Davis ID; Jonasch E; Tamboli P; Yung WK; Weinstein JN; ; Strausberg RL; Yao J
    Clin Cancer Res; 2013 May; 19(9):2460-72. PubMed ID: 23444225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence-based alternative splicing reporters for the study of epithelial plasticity in vivo.
    Somarelli JA; Schaeffer D; Bosma R; Bonano VI; Sohn JW; Kemeny G; Ettyreddy A; Garcia-Blanco MA
    RNA; 2013 Jan; 19(1):116-27. PubMed ID: 23185039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleomycin-enhanced alternative splicing of fibroblast growth factor receptor 2 induces epithelial to mesenchymal transition in lung fibrosis.
    Chen KJ; Li Q; Weng CM; Duan ZX; Zhang DD; Chen ZQ; Chen J; Wang JM
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30049844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells.
    Zhu X; Lee K; Asa SL; Ezzat S
    Am J Pathol; 2007 May; 170(5):1618-28. PubMed ID: 17456767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.